As such, PTEN mutations occur in a subset of diffuse large B-cell lymphoma (DLBCL) and mantle cell lymphoma (MCL) and lead to expression of genes involved in the AKT/mTORC1 pathway [45,46]. The gene discussed is PTEN; the disease is diffuse large B-cell lymphoma.